Biodefense research: Can secrecy and safety coexist?

被引:6
|
作者
Kahn, LH [1 ]
机构
[1] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Program Sci & Global Secur, Princeton, NJ 08542 USA
关键词
D O I
10.1089/153871304323146379
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Over the next 10 years, the United States will spend $6 billion to develop countermeasures against biological and chemical weapons. Much of this research on highly virulent pathogens will be done in academic settings around the country. This article explores the challenges in ensuring secrecy to protect national security while accommodating the right of local communities to have access to safety information regarding select agents and laboratory-acquired infections. Secrecy has been defended as being vital for protecting national security. Problems with secrecy can include the misinterpretation of intentions, particularly in laboratories located in nuclear weapons design facilities, and the restricted access to information relevant to public health and safety. While federal select agent legislation requires laboratories to have emergency plans in place with first responders, these plans do not necessarily include public health professionals, who will be responsible for any future public health action, such as quarantine, surveillance, or mass vaccinations, in the unlikely event that a laboratory-acquired infection spreads into a community. Laboratory-acquired infections do occur, even with the best safety mechanisms in place; however, the epidemiology of the incidence and severity of these infections are not known since there is no national surveillance reporting system. Evidence suggests that many of these infections occur in the absence of an actual laboratory accident. The best emergency plans and surveillance systems are only as good as the participation and vigilance of the laboratory workers themselves. Thus, laboratory workers have a responsibility to themselves and others to report all laboratory accidents and spills, regardless how minor. In addition, they should have a lower threshold than normal in seeking medical attention when feeling ill, and their physicians should be aware of what pathogens they work with to reduce the risk of a delay in diagnosis.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 50 条
  • [1] Biodefense research
    Hampton, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (16): : 2117 - 2117
  • [2] Quantitative and qualitative research methods, can they coexist yet?
    Hunt, Elena
    Lavoie, Anne-Marise
    [J]. RECHERCHE EN SOINS INFIRMIERS, 2011, (105): : 25 - 30
  • [3] Biodefense research halted
    Brainard, Jeffrey
    [J]. SCIENCE, 2019, 365 (6453) : 525 - 525
  • [4] Biodefense research - Accidental anthrax shipment spurs debate over safety
    Enserink, M
    Kaiser, J
    [J]. SCIENCE, 2004, 304 (5678) : 1726 - 1727
  • [5] CAN CULTURES COEXIST
    COUSINS, N
    [J]. TEACHERS COLLEGE RECORD, 1962, 63 (07): : 528 - 536
  • [6] Banning organizational secrecy can threaten research too
    Hirschheim, Rudy
    Lyytinen, Kalle
    [J]. EUROPEAN JOURNAL OF INFORMATION SYSTEMS, 1994, 3 (02) : 83 - 84
  • [7] Agricultural Research Service: Biodefense Research
    Gay, C. G.
    [J]. VACCINES AND DIAGNOSTICS FOR TRANSBOUNDARY ANIMAL DISEASES, 2013, 135 : 23 - 37
  • [8] Biodefense research: an emerging conundrum
    Atlas, RM
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2005, 16 (03) : 239 - 242
  • [9] Hidden costs of biodefense research
    Barthold, SW
    [J]. ILAR JOURNAL, 2005, 46 (01) : 1 - 3
  • [10] Secrecy and safety
    Daughety, AF
    Reinganum, JF
    [J]. AMERICAN ECONOMIC REVIEW, 2005, 95 (04): : 1074 - 1091